We use our own cookies and third parties ones to offer our services and collect statistical data. If you continue browsing the internet you accept them. More information

University of Oslo

Ping Qin

Principal Investigator

Professor Ping Qin, MD, PhD, is head of research group for register-based study on suicide and self-harm at National Centre for Suicide Research and Prevention, University of Oslo, Norway. She is past Vice-President of IASP and co-chair of the IASR/AFSP International Summit in 2019 and 2023. Her main focus of research has been quantitative investigation on contextual influence of multifactorial exposures on risk for suicidal behaviour and follow-up care for people with deliberate self-harm. She has since 1997 led a range of large research projects using data from population registries.

Lars Mehlum

Professor Lars Mehlum MD PhD is the founding director of the National Centre for Suicide Research and Prevention, University of Oslo, Norway. His research focuses on clinical and epidemiological aspects of suicidal behaviour and implementation and scientific evaluation of interventions for suicidal people, such as Dialectical Behaviour therapy. He is a past president of the IASR and IASP and several other international organizations and over several decades he has been actively involved in developing national suicide preventive strategies in Norway and a number of countries throughout the world.

Busenur Kizilaslan

Busenur Kizilaslan is a researcher at the National Centre for Suicide Research and Prevention, University of Oslo, Norway. She is a statistician with a Ph.D. in machine learning, and her particular interests include uncertainty quantification and the development of trustworthy artificial intelligence methods in healthcare.

The PERMANENS project is supported by Instituto de Salud Carlos III (ISCIII) and by the European Union NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (AC22/00006; AC22/00045), the Swedish Innovation Agency (no. 2022-00549), the Research Council of Norway (project no. 342386) and the Health Research Board Ireland (ERAPERMED2022) under the frame of ERA PerMed.